Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.

Woman hoovering the floor

The study, published today in the British Journal of Sports Medicine, is among the first to evaluate how lower cancer risk is associated with light intensity activities such as casual walking, shopping and performing household chores.

The researchers used data from 85,394 UK Biobank participants (median age of 63) to examine how different activity levels might influence the risk of cancer. The participants wore wrist-based activity trackers that tracked total daily activity, activity intensity, and daily step count over a period of one week. The researchers then looked at the relationship between the daily averages and future cancer diagnoses in 2,633 participants over an average follow-up period of 5.8 years.

Key findings

  • Individuals with the highest total amount of daily physical activity had a 26% lower risk of developing cancer than individuals who had the lowest amount of daily physical activity.
  • Light-intensity and moderate-to-vigorous physical activity were associated with lower cancer risk, reinforcing the potential benefits of even light daily movement.
  • Higher daily step counts, but not the pace of the steps, were associated with lower risk of cancer, with risk appearing to plateau at approximately 9,000 steps per day.

 

Read the full story on the  Nuffield Department of Population Health website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience